Therapeutic Options in IgG4-Related Disease

被引:0
作者
Andreu Fernández-Codina
Olimpia Orozco-Gálvez
Fernando Martínez-Valle
机构
[1] Hospital Universitari Vall d’Hebron,General Internal Medicine department, Systemic Autoimmune Diseases unit
[2] University of Western Ontario,Rheumatology division
[3] University of Western Ontario,General Internal Medicine department
来源
Current Treatment Options in Rheumatology | 2020年 / 6卷
关键词
IgG4-related disease; Treatment; Autoimmunity; DMARDs; Rituximab; Glucocorticoids;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:191 / 204
页数:13
相关论文
共 471 条
[21]  
Kodama Y(2017)Standard steroid treatment for autoimmune pancreatitis Clin Transl Gastroenterol 8 e90-1488
[22]  
Sekiguchi K(2017)Azathioprine maintenance therapy to prevent relapses in autoimmune pancreatitis Sci Rep 7 6195-689
[23]  
Kuwada T(2019)Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids Int J Rheum Dis 22 1479-1936
[24]  
Tomono T(2017)Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: a prospective clinical trial Intern Med J 47 680-60
[25]  
Kuriyama K(2015)Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review Rheumatol (United Kingdom) 54 1934-12
[26]  
Mattoo H(2019)Methotrexate for maintenance of remission in igg4-related disease Rheumatology (Oxford) 58 52-894
[27]  
Mahajan VS(2018)Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial Arthritis Res Ther 20 1-1683
[28]  
Della-Torre E(2019)Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: A prospective study of 215 patients Mod Rheumatol 29 892-1177
[29]  
Sekigami Y(2014)Effectiveness of tacrolimus on IgG4-related disease Am J Gastroenterol 109 1675-1578
[30]  
Carruthers M(2015)Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort Ann Rheum Dis 74 1171-260